Skip to main content
Top

08-02-2019 | Continuous glucose monitoring | Patient and physician’s perspective | Article

Use of Continuous Glucose Monitoring in People with Type 1 Diabetes: Perspectives of Two People with Diabetes and Physician Perspective

Journal: Diabetes Therapy

Authors: Isra Ahmed Mohamed, Anthony Fisher, Philippa Cooper, Sufyan Hussain

Publisher: Springer Healthcare

Abstract

This article details perspectives from two individuals with type 1 diabetes (T1DM) who use continuous glucose monitoring (CGM) devices to improve their quality of life and self-management of diabetes. It provides a unique perspective of how CGM can make living with T1DM safer and easier, while improving the time spent in the target glucose range (time in range). The perspectives of these two individuals highlight both the immediate need for improved access and support for CGM as well as the need for an understanding of the benefits of using non-medically approved technologies.
Literature
1.
Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317(4):371–8. https://​doi.​org/​10.​1001/​jama.​2016.​19975.PubMedCrossRef
2.
Scheiner G. CGM retrospective data analysis. Diabetes Technol Ther. 2016;18[Suppl 2]:S2-14–22.CrossRef
3.
Wilmot E, Leelarathna L. Flash forward: a review of flash glucose monitoring. Diabet Med. 2018;35:472–82. https://​doi.​org/​10.​1111/​dme.​13584.PubMedCrossRef
4.
Crabtree TSJ, Sathyapalan T, Wilmot E. FreeStyle Libre: available on the NHS? Br J Diabetes. 2018;18:3–6. https://​doi.​org/​10.​15277/​bjd.​2018.​168.CrossRef
5.
Diabetes UK (2017). Diabetes UK consensus guideline for flash glucose monitoring. Available at: https://​www.​diabetes.​org.​uk/​resources-s3/​2017-09/​1190_​Flash%20​glucose%20​monitoring%20​guideline_​SB_​V9%5B4%5D.​pdf. Accessed 5 Jan 2019.
6.
The Nightscout Foundation. The Nightscout project. Available from: http://​www.​nightscout.​info. Accessed 25 Oct 2018.
7.
Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor. Diabetes Care. 2006;29(1):44–50. https://​doi.​org/​10.​2337/​diacare.​29.​01.​06.​dc05-1686.PubMedCrossRef
8.
Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1c with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Therap. 2007;9:203–10. https://​doi.​org/​10.​1089/​dia.​2007.​0205.CrossRef
9.
Polonsky WH, Hessler D, Ruedy KJ, Beck RW. The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial. Diabetes Care. 2017;40(6):736–41.PubMedCrossRef
10.
JDRF Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464–76.CrossRef
11.
Pickup JC, Holloway MF, Samsi K. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives. Diabetes Care. 2015;38(4):544–50.PubMed
12.
Parkin CG, Holloway M, Truesdell J, Walker TC. Is continuous glucose monitoring underappreciated in the UK? Eur Endocrinol. 2017;13(2):76–80.PubMedPubMedCentralCrossRef
13.
National Institute for Health and Care Excellence (NICE). Type 1 diabetes in adults: diagnosis and management. NICE Guideline {NG17}. 2015. Available from: https://​www.​nice.​org.​uk/​guidance/​ng17. Accessed 25 Oct 2018.
14.
NHS Digital (2018). National diabetes insulin pump audit (NDIPA) 2016–2017. England and Wales. Available at: https://​digital.​nhs.​uk/​data-and-information/​publications/​statistical/​national-diabetes-audit/​insulin-pump-report-2016-17. Accessed 30 Oct 2018.
15.
Perera R, Oliver N, Wilmot E, Marriott C. Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England. Diabet Med. 2018;35(11):1617–8.PubMedCrossRef
16.
NHS Digital (2017) National diabetes audit, 2016–2017, Report 1: care processes and treatment targets. England and Wales. Available at: https://​digital.​nhs.​uk/​data-and-information/​publications/​statistical/​national-diabetes-audit/​national-diabetes-audit-report-1-care-processes-and-treatment-targets-2016-17. Accessed 30 Oct 2018.
17.
Diabetes UK (2018). Type 1 diabetes technology: a consensus guidelines. Available at: https://​www.​diabetes.​org.​uk/​resources-s3/​2018-06/​Diabetes%20​UK%20​consensus%20​guideline.​pdf. Accessed 30 Oct 2018.
18.
Fisher A. BGONMYWATCH. Available at: www.​bgonmywatch.​com. Accessed 30 Oct 2018.

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »